FoxBio Company

FoxBio is a developer of a small molecules techniques intended to reduce senescent cells in human bodies. The company's techniques targets the pro-survival pathways of senescent cells to remove them from the body, enabling patients to have multiple health benefits and delay the onset of age related diseases.
Technology: Geroscience
Industry: Others
Headquarters: United States
Founded Date: 7-12
Investors Number: 2
Total Funding: $10M
Last Funding Type: Venture - Series Unknown

Register and Claim Ownership